aprotinin
PolandDrugs containing this active substance
-
It is a tissue adhesive used in plastic and reconstructive surgery, as well as in the treatment of burns. It is used, among other things, for bonding skin grafts or flaps and for adhering artificial skin to the wound site.
Form: solution for preparation of tissue adhesive
Active substance Dosage human fibrinogen 1 mg/ml aprotinin 3000 KIU/ml calcium chloride dihydrate 40 mcmol/ml human thrombin 4 j.m./ml Manufacturer: Takeda Manufacturing Austria AG
-
It is a tissue adhesive used by surgeons as support in the healing process. It helps improve blood clotting, facilitates wound healing, serves as a sealing material for sutures in vascular and gastrointestinal surgery, and helps in bonding tissues, for example, when fixing skin grafts.
Form: solution for preparation of tissue adhesive
Active substance Dosage aprotinin 3000 KIU fibrinolysin humanum 91 mg thrombin 4 500 j.m. calcium chloride dihydrate 40 mcmol ATC: V03A
Manufacturer: Takeda Manufacturing Austria AG
-
It is a two-component tissue adhesive used by surgeons as a support when standard methods are insufficient. It helps improve blood clotting, serves as an adhesive to facilitate wound healing, acts as a sealant for sutures in vascular and gastrointestinal surgery, or for adhering tissues, e.g., when fixing skin grafts.
Form: powder and solvent for preparation of tissue adhesive solution
Active substance Dosage aprotinin 3000 KIU calcium chloride dihydrate 40 mcmol human fibrinogen 91 mg human thrombin 500 j.m. ATC: V03A
Manufacturer: Takeda Manufacturing Austria AG
-
The medicine is used to reduce blood loss and limit the need for blood transfusion during and after heart surgery. It is intended for patients at increased risk of heavy blood loss who are to undergo heart bypass surgery using cardiopulmonary bypass.
Form: solution for infusion
Active substance Dosage aprotinin 10 g ATC: B02AB01
Manufacturer: Apotek Produktion & Laboratorier AB (APL) Fresenius Kabi Austria GmbH